An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity

Neuropharmacology

Volumn 99, Issue , 2015, Pages 242-255

  Lovelace, Jonathan W ^a   Corches, Alex ^a   Vieira, Philip A ^a   Hiroto, Alex S ^a   Mackie, Ken ^b   Korzus, Edward ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Adolescent cannabis abuse; Cannabinoids; CB1R; LTD; mGluR2 3

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 [BIS(1,3 BENZODIOXOL 5 YL)HYDROXYMETHYL] 1 PIPERIDINECARBOXYLIC ACID 4 NITROPHENYL ESTER; ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; BENZOXAZINE DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CNR1 PROTEIN, MOUSE; ENDOCANNABINOID; METABOTROPIC RECEPTOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GLUTAMATERGIC SYNAPSE; HYDROLYSIS; LOCAL FIELD POSTSYNAPTIC POTENTIAL; LOCOMOTION; LONG TERM DEPRESSION; MEDIAL PREFRONTAL CORTEX; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC PLASTICITY; PRIORITY JOURNAL; SHORT TERM DEPRESSION; SHORT TERM PLASTICITY; SHORT TERM POTENTIATION; SYNAPTIC TRANSMISSION; AGONISTS; ANIMAL; C57BL MOUSE; CANNABIS ADDICTION; CHEMICALLY INDUCED; COGNITIVE DEFECT; DISEASE MODEL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LONG TERM POTENTIATION; METABOLISM; NERVE ENDING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY; RECOGNITION; TISSUE CULTURE TECHNIQUE;

ANIMALS; BENZOXAZINES; CANNABINOID RECEPTOR AGONISTS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; FEMALE; LONG-TERM POTENTIATION; MARIJUANA ABUSE; MICE, INBRED C57BL; MORPHOLINES; NAPHTHALENES; PREFRONTAL CORTEX; PRESYNAPTIC TERMINALS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, METABOTROPIC GLUTAMATE; RECOGNITION (PSYCHOLOGY); TISSUE CULTURE TECHNIQUES;

EID: 84939453460     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.04.034     Document Type: Article

References (103)

1. S.K. Acheson, N.L. Moore, C.M. Kuhn, W.A. Wilson, and H.S. Swartzwelder The synthetic cannabinoid WIN 55212-2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals Neurosci. Lett. 487 2011 411 414
2. P.M. Anderson, D. Pinault, T.J. O'Brien, and N.C. Jones Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical gamma oscillations Int. J. Neuropsychopharmacol. 2014 1 10
3. L. Arseneault, M. Cannon, J. Witton, and R.M. Murray Causal association between cannabis and psychosis: examination of the evidence Br. J. Psychiatry 184 2004 110 117
4. B.K. Atwood, J. Huffman, A. Straiker, and K. Mackie JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist Br. J. Pharmacol. 160 2010 585 593
5. B.K. Atwood, D. Lee, A. Straiker, T.S. Widlanski, and K. Mackie CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists Eur. J. Pharmacol. 659 2011 139 145
6. G. Bedi, R.W. Foltin, E.W. Gunderson, J. Rabkin, C.L. Hart, S.D. Comer, S.K. Vosburg, and M. Haney Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study Psychopharmacology (Berl) 212 2010 675 686
7. M.A. Benneyworth, Z. Xiang, R.L. Smith, E.E. Garcia, P.J. Conn, and E. Sanders-Bush A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis Mol. Pharmacol. 72 2007 477 484
8. A.L. Bodor, I. Katona, G. Nyiri, K. Mackie, C. Ledent, N. Hajos, and T.F. Freund Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types J. Neurosci. 25 2005 6845 6856
9. S.R. Bradley, M.J. Marino, M. Wittmann, S.T. Rouse, H. Awad, A.I. Levey, and P.J. Conn Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata J. Neurosci. 20 2000 3085 3094
10. C.S. Breivogel, S.R. Childers, S.A. Deadwyler, R.E. Hampson, L.J. Vogt, and L.J. Sim-Selley Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain J. Neurochem. 73 1999 2447 2459
11. A. Caspi, T.E. Moffitt, M. Cannon, J. McClay, R. Murray, H. Harrington, A. Taylor, L. Arseneault, B. Williams, A. Braithwaite, R. Poulton, and I.W. Craig Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction Biol. Psychiatry 57 2005 1117 1127
12. M.S. Castaneto, D.A. Gorelick, N.A. Desrosiers, R.L. Hartman, S. Pirard, and M.A. Huestis Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications Drug Alcohol Depend. 144 2014 12 41
13. C.M. Chen, A.D. Stanford, X. Mao, A. Abi-Dargham, D.C. Shungu, S.H. Lisanby, C.E. Schroeder, and L.S. Kegeles GABA level, gamma oscillation, and working memory performance in schizophrenia Neuroimage Clin. 4 2014 531 539
14. S. Choi, and D.M. Lovinger Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression J. Neurosci. 17 1997 8613 8620
15. S. Choi, and D.M. Lovinger Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses Proc. Natl. Acad. Sci. U. S. A. 94 1997 2665 2670
16. C.F. Crispim Junior, C.N. Pederiva, R.C. Bose, V.A. Garcia, C. Lino-de-Oliveira, and J. Marino-Neto ETHOWATCHER: validation of a tool for behavioral and video-tracking analysis in laboratory animals Comput. Biol. Med. 42 2012 257 264
17. D.C. D'Souza, M. Ranganathan, G. Braley, R. Gueorguieva, Z. Zimolo, T. Cooper, E. Perry, and J. Krystal Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis Neuropsychopharmacology 33 2008 2505 2516
18. T.L. Daigle, C.S. Kearn, and K. Mackie Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling Neuropharmacology 54 2008 36 44
19. V.S. Dalton, L.E. Long, C.S. Weickert, and K. Zavitsanou Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex Neuropsychopharmacology 36 2011 1620 1630
20. V.S. Dalton, and K. Zavitsanou Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210 Synapse 64 2010 845 854
21. M. Di Forti, A. Marconi, E. Carra, S. Fraietta, A. Trotta, M. Bonomo, F. Bianconi, P. Gardner-Sood, J. O'Connor, M. Russo, S.A. Stilo, T.R. Marques, V. Mondelli, P. Dazzan, C. Pariante, A.S. David, F. Gaughran, Z. Atakan, C. Iyegbe, J. Powell, C. Morgan, M. Lynskey, and R.M. Murray Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study Lancet Psychiatry 2 2015 233 238
22. E. Fernandez-Espejo, M.-P. Viveros, L. Núñez, B.A. Ellenbroek, and F. Rodriguez de Fonseca Role of cannabis and endocannabinoids in the genesis of schizophrenia Psychopharmacology 206 2009 531 549
23. N.F. Forbes, L.A. Carrick, A.M. McIntosh, and S.M. Lawrie Working memory in schizophrenia: a meta-analysis Psychol. Med. 39 2009 889 905
24. R.T. Fremeau Jr., K. Kam, T. Qureshi, J. Johnson, D.R. Copenhagen, J. Storm-Mathisen, F.A. Chaudhry, R.A. Nicoll, and R.H. Edwards Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites Science 304 2004 1815 1819
25. R.T. Fremeau Jr., S. Voglmaier, R.P. Seal, and R.H. Edwards VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate Trends Neurosci. 27 2004 98 103
26. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol. Rev. 83 2003 1017 1066
27. R.R. Gainetdinov, R.T. Premont, L.M. Bohn, R.J. Lefkowitz, and M.G. Caron Desensitization of G protein-coupled receptors and neuronal functions Annu. Rev. Neurosci. 27 2004 107 144
28. R. Galici, C.K. Jones, K. Hemstapat, Y. Nong, N.G. Echemendia, L.C. Williams, T. de Paulis, and P.J. Conn Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice J. Pharmacol. Exp. Ther. 318 2006 173 185
29. G. Gerdeman, and D.M. Lovinger CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J. Neurophysiol. 85 2001 468 471
30. G.L. Gerdeman, and D.M. Lovinger Emerging roles for endocannabinoids in long-term synaptic plasticity Br. J. Pharmacol. 140 2003 781 789
31. N. Gogtay, J.N. Giedd, L. Lusk, K.M. Hayashi, D. Greenstein, A.C. Vaituzis, T.F. Nugent 3rd, D.H. Herman, L.S. Clasen, A.W. Toga, J.L. Rapoport, and P.M. Thompson Dynamic mapping of human cortical development during childhood through early adulthood Proc. Natl. Acad. Sci. U. S. A. 101 2004 8174 8179
32. T.E. Goldberg, M.F. Egan, T. Gscheidle, R. Coppola, T. Weickert, B.S. Kolachana, D. Goldman, and D.R. Weinberger Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia Arch. Gen. Psychiatry 60 2003 889 896
33. S. Gonzalez, M. Cebeira, and J. Fernandezruiz Cannabinoid tolerance and dependence: a review of studies in laboratory animals Pharmacol. Biochem. Behav. 81 2005 300 318
34. T. Harkany, K. Mackie, and P. Doherty Wiring and firing neuronal networks: endocannabinoids take center stage Curr. Opin. Neurobiol. 18 2008 338 345
35. B.D. Heifets, and P.E. Castillo Endocannabinoid signaling and long-term synaptic plasticity Annu. Rev. Physiol. 71 2009 283 306
36. M.L. Hermes, and L.P. Renaud Postsynaptic and presynaptic group II metabotropic glutamate receptor activation reduces neuronal excitability in rat midline paraventricular thalamic nucleus J. Pharmacol. Exp. Ther. 336 2011 840 849
37. C.M. Hempel, K.H. Hartman, X.J. Wang, G.G. Turrigiano, and S.B. Nelson Multiple forms of short-term plasticity at excitatory synapses in rat medial prefrontal cortex J. Neurophysiol. 83 2000 3031 3041
38. J.C. Hirsch, and F. Crepel Use-dependent changes in synaptic efficacy in rat prefrontal neurons in vitro J. Physiol. 427 1990 31 49
39. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, C.C. Felder, M. Herkenham, K. Mackie, B.R. Martin, R. Mechoulam, and R.G. Pertwee International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2002 161 202
40. C.C. Huang, S.W. Lo, and K.S. Hsu Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons J. Physiol. 532 2001 731 748
41. M.J. Hunt, and S. Kasicki A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo J. Psychopharmacol. 27 2013 972 986
42. W. Jin, S. Brown, J.P. Roche, C. Hsieh, J.P. Celver, A. Kovoor, C. Chavkin, and K. Mackie Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization J. Neurosci. 19 1999 3773 3780
43. K.A. Johnson, C.M. Niswender, P.J. Conn, and Z. Xiang Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata Neurosci. Lett. 504 2011 102 106
44. K.M. Jung, M. Sepers, C.M. Henstridge, O. Lassalle, D. Neuhofer, H. Martin, M. Ginger, A. Frick, N.V. DiPatrizio, K. Mackie, I. Katona, D. Piomelli, and O.J. Manzoni Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome Nat. Commun. 3 2012 1080
45. F. Kasanetz, M. Lafourcade, V. Deroche-Gamonet, J.M. Revest, N. Berson, E. Balado, J.F. Fiancette, P. Renault, P.V. Piazza, and O.J. Manzoni Prefrontal synaptic markers of cocaine addiction-like behavior in rats Mol. Psychiatry 18 2013 729 737
46. I. Katona, B. Sperlagh, A. Sik, A. Kafalvi, E.S. Vizi, K. Mackie, and T.F. Freund Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons J. Neurosci. 19 1999 4544 4558
47. I. Katona, G.M. Urban, M. Wallace, C. Ledent, K.M. Jung, D. Piomelli, K. Mackie, and T.F. Freund Molecular composition of the endocannabinoid system at glutamatergic synapses J. Neurosci. 26 2006 5628 5637
48. J.N. Kew, M.C. Pflimlin, J.A. Kemp, and V. Mutel Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice Neuropharmacology 43 2002 215 221
49. E. Korzus, M.G. Rosenfeld, and M. Mayford CBP histone acetyltransferase activity is a critical component of memory consolidation Neuron 42 2004 961 972
50. M. Lafourcade, I. Elezgarai, S. Mato, Y. Bakiri, P. Grandes, and O.J. Manzoni Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex PLoS ONE 2 2007 e709
51. K. Limback-Stokin, E. Korzus, R. Nagaoka-Yasuda, and M. Mayford Nuclear calcium/calmodulin regulates memory consolidation J. Neurosci. 24 2004 10858 10867
52. J.Z. Long, W. Li, L. Booker, J.J. Burston, S.G. Kinsey, J.E. Schlosburg, F.J. Pavon, A.M. Serrano, D.E. Selley, L.H. Parsons, A.H. Lichtman, and B.F. Cravatt Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat. Chem. Biol. 5 2009 37 44
53. M. López-Gallardo, A.B. López-Rodríguez, Á. Llorente-Berzal, D. Rotllant, K. Mackie, A. Armario, R. Nadal, and M.P. Viveros Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion Neuroscience 204 2012 90 103
54. J.W. Lovelace, P.A. Vieira, A. Corches, K. Mackie, and E. Korzus Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity Neuropsychopharmacology 39 2014 1685 1693
55. D.M. Lovinger Presynaptic modulation by endocannabinoids Handb. Exp. Pharmacol. 184 2008 435 477
56. D.M. Lovinger Presynaptic modulation by endocannabinoids Handb. Exp. Pharmacol. 2008 435 477
57. S. Luzi, P.D. Morrison, J. Powell, M. di Forti, and R.M. Murray What is the mechanism whereby cannabis use increases risk of psychosis? Neurotox. Res. 14 2008 105 112
58. K. Mackie Signaling via CNS cannabinoid receptors Mol. Cell. Endocrinol. 286 2008 S60 S65
59. J.K. Makara, M. Mor, D. Fegley, S.I. Szabo, S. Kathuria, G. Astarita, A. Duranti, A. Tontini, G. Tarzia, S. Rivara, T.F. Freund, and D. Piomelli Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus Nat. Neurosci. 8 2005 1139 1141
60. E. Manrique-Garcia, S. Zammit, C. Dalman, T. Hemmingsson, S. Andreasson, and P. Allebeck Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort Psychol. Med. 2011 1 8
61. W.R. Marrs, J.L. Blankman, E.A. Horne, A. Thomazeau, Y.H. Lin, J. Coy, A.L. Bodor, G.G. Muccioli, S.S. Hu, G. Woodruff, S. Fung, M. Lafourcade, J.P. Alexander, J.Z. Long, W. Li, C. Xu, T. Moller, K. Mackie, O.J. Manzoni, B.F. Cravatt, and N. Stella The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors Nat. Neurosci. 13 2010 951 957
62. L. Martini, D. Thompson, V. Kharazia, and J.L. Whistler Differential regulation of behavioral tolerance to WIN55,212-2 by GASP1 Neuropsychopharmacology 35 2010 1363 1373
63. S. Mato, V. Chevaleyre, D. Robbe, A. Pazos, P.E. Castillo, and O.J. Manzoni A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity Nat. Neurosci. 7 2004 585 586
64. ++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens Neuropharmacology 54 2008 87 94
65. S. Mato, D. Robbe, N. Puente, P. Grandes, and O.J. Manzoni Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure J. Neurosci. 25 2005 11619 11627
66. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
67. R. Mechoulam, and Y. Gaoni A total synthesis of Dl-Delta-1-tetrahydrocannabinol, the active constituent of Hashish J. Am. Chem. Soc. 87 1965 3273 3275
68. M.H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts, R.S. Keefe, K. McDonald, A. Ward, R. Poulton, and T.E. Moffitt Persistent cannabis users show neuropsychological decline from childhood to midlife Proc. Natl. Acad. Sci. U. S. A. 109 2012 E2657 E2664
69. D.J. Morgan, B.J. Davis, C.S. Kearn, D. Marcus, A.J. Cook, J. Wager-Miller, A. Straiker, M.H. Myoga, J. Karduck, E. Leishman, L.J. Sim-Selley, T.A. Czyzyk, H.B. Bradshaw, D.E. Selley, and K. Mackie Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice J. Neurosci. 34 2014 5152 5163
70. S.H. Morris, S. Knevett, E.G. Lerner, and L.J. Bindman Group I mGluR agonist DHPG facilitates the induction of LTP in rat prelimbic cortex in vitro J. Neurophysiol. 82 1999 1927 1933
71. P.T. Nguyen, C.L. Schmid, K.M. Raehal, D.E. Selley, L.M. Bohn, and L.J. Sim-Selley Beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner Biol. Psychiatry 71 2012 714 724
72. G. Nyiri, C. Cserep, E. Szabadits, K. Mackie, and T.F. Freund CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons Neuroscience 136 2005 811 822
73. M. O'Shea, M.E. Singh, I.S. McGregor, and P.E. Mallet Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats J. Psychopharmacol. 18 2004 502 508
74. T. Ohno-Shosaku, A. Tanimura, Y. Hashimotodani, and M. Kano Endocannabinoids and retrograde modulation of synaptic transmission Neuroscientist 18 2011 119 132
75. S. Otani, N. Auclair, J.M. Desce, M.P. Roisin, and F. Crepel Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases J. Neurosci. 19 1999 9788 9802
76. S. Otani, H. Daniel, M. Takita, and F. Crepel Long-term depression induced by postsynaptic group II metabotropic glutamate receptors linked to phospholipase C and intracellular calcium rises in rat prefrontal cortex J. Neurosci. 22 2002 3434 3444
77. D. Piomelli The molecular logic of endocannabinoid signalling Nat. Rev. Neurosci. 4 2003 873 884
78. H.R. Quinn, I. Matsumoto, P.D. Callaghan, L.E. Long, J.C. Arnold, N. Gunasekaran, M.R. Thompson, B. Dawson, P.E. Mallet, M.A. Kashem, H. Matsuda-Matsumoto, T. Iwazaki, and I.S. McGregor Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure Neuropsychopharmacology 33 2008 1113 1126
79. S.M. Raver, S.P. Haughwout, and A. Keller Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice Neuropsychopharmacology 38 2013 2338 2347
80. N. Realini, D. Vigano, C. Guidali, E. Zamberletti, T. Rubino, and D. Parolaro Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats Neuropharmacology 60 2011 235 243
81. A. Reichenberg, A. Caspi, H. Harrington, R. Houts, R.S. Keefe, R.M. Murray, R. Poulton, and T.E. Moffitt Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study Am. J. Psychiatry 167 2010 160 169
82. 2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses J. Neurosci. 22 2002 4346 4356
83. T. Rubino, and D. Parolaro Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence Prog. Neuropsychopharmacol. Biol. Psychiatry 52 2014 41 44
84. T. Rubino, P. Prini, F. Piscitelli, E. Zamberletti, M. Trusel, M. Melis, C. Sagheddu, A. Ligresti, R. Tonini, V. Di Marzo, and D. Parolaro Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex Neurobiol. Dis. 73 2015 60 69
85. T. Rubino, N. Realini, D. Braida, T. Alberio, V. Capurro, D. Vigano, C. Guidali, M. Sala, M. Fasano, and D. Parolaro The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex Neurotox. Res. 15 2009 291 302
86. T. Rubino, D. Vigano, N. Realini, C. Guidali, D. Braida, V. Capurro, C. Castiglioni, F. Cherubino, P. Romualdi, S. Candeletti, M. Sala, and D. Parolaro Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates Neuropsychopharmacology 33 2008 2760 2771
87. T. Rubino, E. Zamberletti, and D. Parolaro Adolescent exposure to cannabis as a risk factor for psychiatric disorders J. Psychopharmacol. 26 2011 177 188
88. C. Sales-Carbonell, P.E. Rueda-Orozco, E. Soria-Gomez, G. Buzsaki, G. Marsicano, and D. Robbe Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony Proc. Natl. Acad. Sci. U. S. A. 110 2013 719 724
89. M. Schneider, E. Drews, and M. Koch Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2 Behav. Pharmacol. 16 2005 447 454
90. M. Schneider, and M. Koch Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats Neuropsychopharmacology 28 2003 1760 1769
91. P.D. Skosnik, D.C. D'Souza, A.B. Steinmetz, C.R. Edwards, J.M. Vollmer, W.P. Hetrick, and B.F. O'Donnell The effect of chronic cannabinoids on broadband EEG neural oscillations in humans Neuropsychopharmacology 37 2012 2184 2193
92. N. Solowij, R.S. Stephens, R.A. Roffman, T. Babor, R. Kadden, M. Miller, K. Christiansen, B. McRee, and J. Vendetti Cognitive functioning of long-term heavy cannabis users seeking treatment JAMA 287 2002 1123 1131
93. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
94. A. Straiker, S.S. Hu, J.Z. Long, A. Arnold, J. Wager-Miller, B.F. Cravatt, and K. Mackie Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons Mol. Pharmacol. 76 2009 1220 1227
95. A. Thomazeau, O. Lassalle, J. Iafrati, B. Souchet, F. Guedj, N. Janel, P. Chavis, J. Delabar, and O.J. Manzoni Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a J. Neurosci. 34 2014 1138 1147
96. K. Tsou, K. Mackie, M.C. Sanudo-Pena, and J.M. Walker Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation Neuroscience 93 1999 969 975
97. P.J. Uhlhaas, and W. Singer High-frequency oscillations and the neurobiology of schizophrenia Dialogues Clin. Neurosci. 15 2013 301 313
98. H. Ujike, and Y. Morita New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia J. Pharmacol. Sci. 96 2004 376 381
99. UNODC World Drug Report 2012 2012 United Nations Publications New York NY
100. A.G. Walker, C.J. Wenthur, Z. Xiang, J.M. Rook, K.A. Emmitte, C.M. Niswender, C.W. Lindsley, and P.J. Conn Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction Proc. Natl. Acad. Sci. U. S. A. 112 2015 1196 1201
101. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 2001 588 592
102. M. Yokoi, K. Kobayashi, T. Manabe, T. Takahashi, I. Sakaguchi, G. Katsuura, R. Shigemoto, H. Ohishi, S. Nomura, K. Nakamura, K. Nakao, M. Katsuki, and S. Nakanishi Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2 Science 273 1996 645 647
103. E. Zamberletti, S. Beggiato, L. Steardo Jr., P. Prini, T. Antonelli, L. Ferraro, T. Rubino, and D. Parolaro Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats Neurobiol. Dis. 63 2014 35 47